Response of Cytosolic Calcium, Cyclic AMP, and Cyclic GMP in Dimethylsulfoxide-Differentiated HL-60 Cells to Modulated Low Frequency Electric Currents

Bioelectromagnetics

Volumn 19, Issue 8, 1998, Pages 452-458

  Sontag, W ^a   Dertinger, H ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Amplitude modulation; Cyclic AMP; Cyclic GMP; Cytosolic free calcium; HL 60 cells; Low frequency electric fields and currents

Indexed keywords

CALCIUM; CELL CULTURE; CURRENT DENSITY; ELECTRIC FIELDS; FREQUENCY MODULATION; SIGNAL TRANSDUCTION;

'CURRENT; CYCLIC AMP; CYCLIC GMP; CYTOSOLIC FREE CALCIUM; DIMETHYLSULPHOXIDES; HL-60 CELLS; LOW FREQUENCY ELECTRIC FIELD AND CURRENT; LOW FREQUENCY ELECTRIC FIELDS; MODULATION FREQUENCIES; MONOPHOSPHATES;

AMPLITUDE MODULATION;

CALCIUM; CYCLIC AMP; CYCLIC GMP; DIMETHYL SULFOXIDE; SCAVENGER;

ANIMAL; ARTICLE; BIOPHYSICS; CELL COUNT; CELL DIFFERENTIATION; CELL STRAIN HL 60; CYTOLOGY; CYTOSOL; ELECTRICITY; ENZYMOLOGY; FIBROBLAST; GRANULOCYTE; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SECOND MESSENGER;

ANIMALS; BIOPHYSICS; CALCIUM; CELL COUNT; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC GMP; CYTOSOL; DIMETHYL SULFOXIDE; ELECTRICITY; FIBROBLASTS; FREE RADICAL SCAVENGERS; GRANULOCYTES; HL-60 CELLS; HUMANS; MICE; SECOND MESSENGER SYSTEMS;

EID: 0032238246     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-186x(1998)19:8<452::aid-bem2>3.0.co;2-a     Document Type: Article

References (25)

1. Adey WR (1990): Electromagnetic fields, cell membrane amplification, and cancer promotion. In Wilson BW, Stevens RG, Anderson LE (eds): "Extremely Low Frequency Electromagnetic Fields: The Question of Cancer." Columbus: Batelle Press, pp 211-249.
2. Astumian RD, Weaver JC, Adair RK (1995): Rectification and signal averaging of weak electric fields by biological cells. Proc Natl Acad Sci USA 92:3740-3743.
3. Benidge M (1985): The molecular basis of communication within the cell. Sci Am 253:142-150.
4. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1979): Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149:969-973.
5. Corbin JD, Thomas MK, Wolfe L, Shabb JB, Woodford TA, Francis SH (1990): New insights into cGMP action. In Nishizuka Y, Endo M, Tanaka C (eds): "Advances in Second Messenger and Phosphoprotein Research. Vol 24." New York: Raven Press, pp 411-418.
6. Douglass JK, Wilkens L, Pantazelou E, Moss F (1993): Noise enhance- ment of information transfer in crayfish mechanoreceptors by stochastic resonance. Nature 365:337-340.
7. Iskander MF (1990): Potential electromagnetic techniques in medical applications. In Gandhi OP (ed): "Biological Effects and Medical Applications of Electromagnetic Energy." Englewood Cliffs NJ: Prentice-Hall, pp 478-528.
8. Knedlitschek G, Noszvai-Nagy M, Meyer-Waarden H, Schimmelpfeng J, Weibezahn KF, Dertinger H (1994): Cyclic AMP response in cells exposed to electric fields of different frequencies and intensities. Radiat Environ Biophys 33:141-147.
9. Kruglikov IL, Dertinger H (1994): Stochastic resonance as a possible mechanism of amplification of weak electric signals in living cells. Bioelectromagnetics 15:539-547.
10. Luben RA (1994): Membrane signal transduction as a site of electromagnetic field actions in bone and other tissues. In Frey AH (ed): "On the Nature of Electromagnetic Field Interactions With Biological Systems." Austin: R.G. Landes Company, pp 83-98.
11. Moss F, Pei X (1995): Neurons in parallel. Nature 376:211-212.
12. Murad F, Ishii K, Förstermann U, Gorsky L, Kerwin JF, Pollock J, Heller H (1990): EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells. In Nishizuka Y, Endo M, Tanaka C (eds): "Advances in Second Messenger and Phosphoprotein Research. Vol 24." New York: Raven Press, pp 441-448.
13. Nikolova L (1987): "Treatment With Interferential Current." New York: Churchill Livingstone.
14. Olashaw NE, Pledger WJ (1988): Cellular mechanisms regulating proliferation. In Greengart P, Robison GA (eds): "Advances in Second Messenger and Phosphoprotein Research. Vol 22." New York: Raven Press, pp 139-173.
15. Perez-Terzic C, Stehno-Bittel L, Clapham DE (1997): Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator fluo-3. Cell Calcium 21:275-282.
16. Rebhun LI (1977): Cyclic nucleotides, calcium, and cell division. Int Rev Cytol 49:1-54.
17. Royer E, Chaintreul J, Meynadier J, Michel B, Guilhou JJ, Crastes de Faulet A (1982): Cyclic AMP and cyclic GMP production in normal and psoriatic epidermis. Dermatologie a 165:533-543.
18. Rozengurt E, Ober SS (1989): Mitogenic signalling in murine 3T3 cells: The cyclic AMP pathway. Biochem Soc Trans 17:629-632.
19. Schmidt K, Graier WF, Kubovetz WR (1990): EDRF-formation increases cGMP-levels in cultured endothelial cells. In Nishizuka Y, Endo M, Tanaka C (eds): "Advances in Second Messenger and Phosphoprotein Research. Vol 24." New York: Raven Press, pp 455-460.
20. Sontag W (1997): Two experimental systems for exposure of cells to extremely low frequency electric fields suitable for in situ measurements of fluorescence signals. Bioelectrochem Bioenerg 44:747-749.
21. Sontag W (1998): The action of extremely low frequency electric fields on the cytosolic calcium concentration of differentiated HL-60 cells: Non-activated cells. Bioelectromagnetics 19:32-40.
22. Tenforde TS (1993): Cellular and molecular pathways of extremely low frequency electromagnetic field interactions with living systems. In Blank M (ed): "Electricity and Magnetism in Biology and Medicine." San Francisco: San Francisco Press, pp 1-8.
23. Tsien RY, Pozzan T, Rink TJ (1982): Calcium homeostasis in intact lymphocytes: Cytoplasmatic free calcium monitors with a new intracellulary trapped fluorescent indicator. J Cell Biol 94:325-334.
24. Ward AR (1980): "Electricity, Fields and Waves in Therapy." Marrickville, NSW, Australia: Science Press.
25. Wolf B, Dertinger H, Wolf G (1996): Die Wirkung von Interferenzstrom auf Psoriasis vulgaris. Akt Dermatol 22:94-97.